Protara Therapeutics, Inc. Share Price
NASDAQ: TARA | Micro CapProtara Therapeutics, Inc. Stock Performance
Protara Therapeutics, Inc. Share Price Today
As of 29 October 2026, Protara Therapeutics, Inc.'s share price is $2.54. The stock opened at $2.52, compared to its previous close of $2.48. During today's trading session, Protara Therapeutics, Inc.'s share price traded between $2.52 and $2.63, with an average price of $2.57. Over the past 52 weeks, the stock has recorded a high of $7.81 and a low of $2.28. In terms of performance, Protara Therapeutics, Inc.'s share price has declined by 52.25% over the last six months and is down 50.87% on a year-on-year basis.
Protara Therapeutics, Inc. Share Price Chart
Protara Therapeutics, Inc. Quarterly Profit & Loss
All figures in USD
Protara Therapeutics, Inc. Annual Profit & Loss
All figures in USD
About Protara Therapeutics, Inc.
Protara Therapeutics Inc is a clinical-stage biopharmaceutical company focused on advancing its therapies for the treatment of cancer and rare diseases. Its drug development pipeline includes: TARA-002, an investigational cell therapy in development for the treatment of non-muscle invasive bladder cancer (NMIBC) and lymphatic malformations (LMs); and IV Choline Chloride, an investigational phospholipid substrate replacement therapy, for patients receiving parenteral support, or PS, which includes both nutrition and fluids.
Protara Therapeutics, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $3.06 | $2.54 | -16.97% |
Sep 2026 | $3.83 | $3.06 | -23.28% |
Aug 2026 | $3.89 | $4.00 | +1.91% |
Jul 2026 | $3.88 | $3.92 | +2.75% |
Jun 2026 | $4.63 | $3.81 | -18.13% |
May 2026 | $5.38 | $4.66 | -12.57% |
Apr 2026 | $5.25 | $5.33 | +2.50% |
Mar 2026 | $6.28 | $5.20 | -18.37% |
Feb 2026 | $7.05 | $6.37 | -10.16% |
Jan 2026 | $5.30 | $7.09 | +33.27% |
Dec 2025 | $7.25 | $5.32 | -27.86% |
Nov 2025 | $5.26 | $7.38 | +42.37% |